DARA BioSciences

DARA BioSciences is a specialty pharmaceutical company established in 2002, with a slogan of "A specialty pharmaceutical company committed to advancing oncology treatment and supportive care products." The company's primary focus lies in the commercialization of oncology treatment and oncology supportive care products. In February 2014, DARA BioSciences received a $6.00M post-IPO equity investment, reflecting investors' confidence in its potential for growth and success. As DARA BioSciences continues to make strides in the biotechnology, pharmaceutical, and platforms industries, its innovative approach to advancing oncology treatments and supportive care products positions it as a compelling prospect for potential venture capital consideration.